NCT01610362View on ClinicalTrials.gov

Human Rabies Immunoglobulin (HRIG)- Dosage Determination and Interference With the Active Immune Response

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

June 30, 2012

Primary Completion Date

April 30, 2018

Study Completion Date

April 30, 2018

Conditions
Rabies
Interventions
BIOLOGICAL

Human Rabies Immune Globulin

HRIG 20 IU/kg and 40 IU/kg would be given once to the volunteers on day 0

Trial Locations (1)

10330

Queen Saovabha Memorial Institute, Thai Red Cross Society, Bangkok

All Listed Sponsors
lead

Queen Saovabha Memorial Institute

OTHER

NCT01610362 - Human Rabies Immunoglobulin (HRIG)- Dosage Determination and Interference With the Active Immune Response | Biotech Hunter | Biotech Hunter